hOKT3γ1 (Ala-Ala)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for hOKT3γ1 (Ala-Ala), covering 2012-03-21 to 2012-08-02. Get the full timeline:
Most recent: Clinical Trial Update: hOKT3γ1 (Ala-Ala) Combined With Sirolimus and Delayed Tacrolimus in Type 1 Diabetic Islet Allograft Recipients [Phase 1, Phase 2]